Emergency Use Authorization (EUA) is an authorization issued for unregistered drugs and vaccines in a public health emergency. The FDA Director General, by virtue of the Executive Order No. 121 of the President of the Philippines, authorizes the issuance of the EUA.
List of COVID-19 Vaccines Authorized by the FDA
List of COVID-19 Drugs Authorized by the FDA
Reports of suspected adverse reaction to COVID-19 vaccines
The FDA publishes an overview of reports of suspected adverse reactions to COVID-19 vaccines that is currently in use in the vaccination program of the Philippines.
The reports of suspected adverse drug reactions issued on a weekly basis have provided timely and relevant information to the healthcare professionals and the public on the safety of COVID-19 vaccines used in the vaccination program of the government as implemented by the National COVID-19 Vaccination Operations Center. In line with the high vaccination coverage and operational strategy, updates will be published quarterly until the end of 2023 then as needed thereafter. Monitoring the safety of COVID-19 vaccines shall remain on a regular interval.
Status as of 30 September 2023
Total number of doses administered: 181,645,251
Number of fully vaccinated individuals: 78,443,972
Number of individuals with booster shots: 23,811,248
Number of reports of suspected adverse reaction: 113,218 (0.06% of doses administered)
To report a suspected side effect, click here.